Kim I - Search Results

1

Combined oral contraceptive synergistically activates mineralocorticoid receptor through histone code modifications.

Igunnu A, Seok YM, Olatunji LA, Kang SH, Kim I. Igunnu A, et al. Among authors: kim i. Eur J Pharmacol. 2015 Dec 15;769:48-54. doi: 10.1016/j.ejphar.2015.10.035. Epub 2015 Oct 23. Eur J Pharmacol. 2015. PMID: 26506558

2

Heat shock-induced augmentation of vascular contractility is independent of rho-kinase.

Seok Y, Kim JI, Ito M, Kureishi Y, Nakano T, Kim SO, Lim DG, Park WH, Kim I. Seok Y, et al. Among authors: kim ji, kim so, kim i. Clin Exp Pharmacol Physiol. 2006 Mar;33(3):264-8. doi: 10.1111/j.1440-1681.2006.04356.x. Clin Exp Pharmacol Physiol. 2006. PMID: 16487272

3

Endothelial dysfunction after exposure to cobalt chloride enhanced vascular contractility.

Seong Y, Kim E, Park TG, Seok Y, Baek W, Kim SO, Lim DG, Yang DH, Kim I. Seong Y, et al. Among authors: kim e, kim so, kim i. Environ Toxicol Pharmacol. 2005 Sep;20(2):297-304. doi: 10.1016/j.etap.2005.02.007. Epub 2005 Mar 31. Environ Toxicol Pharmacol. 2005. PMID: 21783604

4

Enrichment of (pro)renin receptor promoter with activating histone codes in the kidneys of spontaneously hypertensive rats.

Lee HA, Lee DY, Lee HJ, Han HS, Kim I. Lee HA, et al. Among authors: kim i. J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):11-8. doi: 10.1177/1470320311415738. Epub 2011 Jul 29. J Renin Angiotensin Aldosterone Syst. 2012. PMID: 21803797 Free article.

5

Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications.

Lee HA, Cho HM, Lee DY, Kim KC, Han HS, Kim IK. Lee HA, et al. Hypertension. 2012 Mar;59(3):621-6. doi: 10.1161/HYPERTENSIONAHA.111.182428. Epub 2012 Feb 6. Hypertension. 2012. PMID: 22311897

6

2-Morpholinoisoflav-3-enes as flexible intermediates in the synthesis of phenoxodiol, isophenoxodiol, equol and analogues: vasorelaxant properties, estrogen receptor binding and Rho/RhoA kinase pathway inhibition.

Tilley AJ, Zanatta SD, Qin CX, Kim IK, Seok YM, Stewart A, Woodman OL, Williams SJ. Tilley AJ, et al. Bioorg Med Chem. 2012 Apr 1;20(7):2353-61. doi: 10.1016/j.bmc.2012.02.008. Epub 2012 Feb 11. Bioorg Med Chem. 2012. PMID: 22377671

7

Upregulation of the Na(+)-K(+)-2Cl(-) cotransporter 1 via histone modification in the aortas of angiotensin II-induced hypertensive rats.

Cho HM, Lee DY, Kim HY, Lee HA, Seok YM, Kim IK. Cho HM, et al. Hypertens Res. 2012 Aug;35(8):819-24. doi: 10.1038/hr.2012.37. Epub 2012 Apr 12. Hypertens Res. 2012. PMID: 22495607

8

Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension.

Lee HA, Lee DY, Cho HM, Kim SY, Iwasaki Y, Kim IK. Lee HA, et al. Circ Res. 2013 Mar 29;112(7):1004-12. doi: 10.1161/CIRCRESAHA.113.301071. Epub 2013 Feb 19. Circ Res. 2013. PMID: 23421989

9

GPER-1 agonist G1 induces vasorelaxation through activation of epidermal growth factor receptor-dependent signalling pathway.

Jang EJ, Seok YM, Arterburn JB, Olatunji LA, Kim IK. Jang EJ, et al. J Pharm Pharmacol. 2013 Oct;65(10):1488-99. doi: 10.1111/jphp.12113. Epub 2013 Aug 6. J Pharm Pharmacol. 2013. PMID: 24028616

10

Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats.

Kang SH, Seok YM, Song MJ, Lee HA, Kurz T, Kim I. Kang SH, et al. Among authors: kim i. Mol Pharmacol. 2015 May;87(5):782-91. doi: 10.1124/mol.114.096974. Epub 2015 Feb 9. Mol Pharmacol. 2015. PMID: 25667225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,585 results

Search Page

Filters